We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DNB:EURONEXT OSLODNB Bank ASA Analysis

Data as of 2026-08-12 - not real-time

NOK 307.70

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At NOK 307.70, DNB Bank ASA shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Across the trailing 30 sessions it gained 4.4%. RSI sits at 63.8, which reads as approaching overbought, and MACD momentum is bullish. The recent range runs from support at NOK 289.10 up to resistance at NOK 309.80.
Valuation screens as undervalued: a P/E of 11.2 sits below the sector average of 16.9. The 5.88% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 11.2%, a beta of 0.19 and a maximum drawdown of 11.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.

Top Market Events

Seeking Alpha3monDNB Bank ASA DNBBY Q1 2026 Earnings Call TranscriptGood day, and welcome to today's DNB Q1 Conference...Seeking Alpha29dDNB Bank ASA DNBBY Q2 2026 Earnings Call TranscriptHello, and welcome to the DNB Q2 conference call.Detailed price information for Dnb Nor Bank ASA DNBBF from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 286.18
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 11.2 versus sector average of 16.9
  • Trading above the 200-day average of 286.18

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 11.2 versus sector average of 16.9
  • Profit margin of 47.8% is healthy
  • Return on equity of 15.1%

Key Metrics & Analysis

Financial Health

Revenue Growth0.80%
Profit Margin47.83%
P/E Ratio11.2
ROE15.07%
ROA1.09%
P/B Ratio1.7
Op. Cash FlowNOK-167112998912
Industry P/E16.9

Technical Analysis

TrendBullish
RSI63.8
SupportNOK 289.10
ResistanceNOK 309.80
MA 20NOK 301.46
MA 50NOK 296.12
MA 200NOK 286.18
MACDBullish
VolumeDecreasing
Fear & Greed Index95.36

Valuation

Target PriceNOK 305.71
Upside/Downside-0.65%
GradeUndervalued
TypeValue
Dividend Yield5.88%

Risk Assessment

Beta0.19
Volatility11.22%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.